# 129 Xenon Imaging in Patients Treated With Sotatercept

> **NCT06351345** · PHASE2 · RECRUITING · sponsor: **Bastiaan Driehuys** · enrollment: 14 (estimated)

## Conditions studied

- Pulmonary Hypertension
- Pulmonary Arterial Hypertension

## Interventions

- **DRUG:** 129Xe Hyperpolarized

## Key facts

- **NCT ID:** NCT06351345
- **Lead sponsor:** Bastiaan Driehuys
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2025-10-27
- **Primary completion:** 2029-02-04
- **Final completion:** 2030-02-04
- **Target enrollment:** 14 (ESTIMATED)
- **Last updated:** 2026-02-24

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06351345

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06351345, "129 Xenon Imaging in Patients Treated With Sotatercept". Retrieved via AI Analytics 2026-05-25 from https://api.ai-analytics.org/clinical/NCT06351345. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*